Bio-Techne
TECH
#1989
Rank
$9.61 B
Marketcap
$61.68
Share price
-2.93%
Change (1 day)
-16.16%
Change (1 year)
Bio-Techne Corporation is an American holding company for biotechnology and clinical diagnostic brands. The company's brands portfolio includes R&D Systems, Novus Biologicals, Tocris Bioscience, ProteinSimple, Exosome Diagnostics, BiosPacific, Cliniqa, Advanced Cell Diagnostics, RNA Medical, Bionostics and BostonBiochem.

Bio-Techne (TECH) - Net assets

Net assets on the balance sheet as of September 2025 : $1.96 Billion USD

According to Bio-Techne's latest financial reports the company has $1.96 Billion USD in net assets.
A companyโ€™s net assets is the sum of its assets minus the sum of its liabilities.

Bio-Techne - Net assets on balance sheet (from 2001 to 2025)

Net assets by year

Year Net assets Change
2024-06-30$$2.06 B5.2%
2023-06-30$$1.96 B15.61%
2022-06-30$$1.70 B8.26%
2021-06-30$$1.57 B13.76%
2020-06-30$$1.38 B18.5%
2019-06-30$$1.16 B8.02%
2018-06-30$$1.07 B13.63%
2017-06-30$$0.94 B8%
2016-06-30$$0.87 B3.82%
2015-06-30$$0.84 B6.5%
2014-06-30$$0.79 B7.83%
2013-06-30$$0.73 B9.36%
2012-06-30$$0.67 B15.07%
2011-06-30$$0.58 B16.81%
2010-06-30$$0.50 B9.93%
2009-06-30$$0.45 B-6.29%
2008-06-30$$0.48 B11.31%
2007-06-30$$0.43 B28.59%
2006-06-30$$0.34 B27.06%
2005-06-30$$0.26 B-9.94%
2004-06-30$$0.29 B25.7%
2003-06-30$$0.23 B14.58%
2002-06-30$$0.20 B16.24%
2001-06-30$$0.17 B

Net assets for similar companies or competitors

Company Net assets differencediff. Country
Thermo Fisher Scientific
TMO
$51.15 B 2,502.18%๐Ÿ‡บ๐Ÿ‡ธ USA
Bio-Rad Laboratories
BIO
$6.73 B 242.70%๐Ÿ‡บ๐Ÿ‡ธ USA
Becton Dickinson
BDX
$25.47 B 1,195.80%๐Ÿ‡บ๐Ÿ‡ธ USA
Danaher
DHR
$51.08 B 2,498.42%๐Ÿ‡บ๐Ÿ‡ธ USA
Qiagen
QGEN
$3.64 B 85.64%๐Ÿ‡ณ๐Ÿ‡ฑ Netherlands
General Electric
GE
$19.02 B 867.59%๐Ÿ‡บ๐Ÿ‡ธ USA
Enzo Biochem
ENZB
$43.39 M-97.79%๐Ÿ‡บ๐Ÿ‡ธ USA